AAAAAA

   
Results: 1-11 |
Results: 11
HETEROGENEITY OF COGNITIVE DYSFUNCTION IN MULTIPLE-SCLEROSIS
Authors: FISCHER JS JACOBS LD COOKFAIR DL RUDICK RA
Citation: Js. Fischer et al., HETEROGENEITY OF COGNITIVE DYSFUNCTION IN MULTIPLE-SCLEROSIS, Clinical neuropsychologist, 12(2), 1998, pp. 286-286
MAGNETIC-RESONANCE STUDIES OF INTRAMUSCULAR INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: SIMON JH JACOBS LD CAMPION M WENDE K SIMONIAN N COOKFAIR DL RUDICK RA HERNDON RM RICHERT JR SALAZAR AM ALAM JJ FISCHER JS GOODKIN DE GRANGER CV LAJAUNIE M MARTENSDAVIDSON AL MEYER MJ SHEEDER J CHOI K SCHERZINGER AL BARTOSZAK DM BOURDETTE DN BRAIMAN J BROWNSCHEIDLE CM COATS ME COHAN SL DOUGHERTY DS KINKEL RP MASS MK MUNSCHAUER FE PRIORE RL PULLICINO PM SCHEROKMAN BJ WEINSTOCKGUTTMAN B WHITHAM RH
Citation: Jh. Simon et al., MAGNETIC-RESONANCE STUDIES OF INTRAMUSCULAR INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 43(1), 1998, pp. 79-87
NEUROPSYCHOLOGICAL EFFECTS OF AVONEX(R) (INTERFERON-BETA-1A) IN RELAPSING MULTIPLE-SCLEROSIS (MS)
Authors: FISCHER JS PRIORE R JACOBS L COOKFAIR D RUDICK R HERNDON R RICHERT J SALAZAR A GOODKIN D GRANGER C SIMON J GRAFMAN J LEZAK M OREILLY K SCHACTER M SHUCARD D DAVIDSON A WENDE K
Citation: Js. Fischer et al., NEUROPSYCHOLOGICAL EFFECTS OF AVONEX(R) (INTERFERON-BETA-1A) IN RELAPSING MULTIPLE-SCLEROSIS (MS), Neurology, 50(4), 1998, pp. 1070-1070
VALIDATION OF A NEW MULTIPLE-SCLEROSIS CLINICAL OUTCOME MEASURE USINGPATIENT REPORTED QUALITY-OF-LIFE
Authors: MILLER DM FISCHER JS CUTTER G ANDREWS H LAROCCA NG PATY D RITVO P RUDICK RA
Citation: Dm. Miller et al., VALIDATION OF A NEW MULTIPLE-SCLEROSIS CLINICAL OUTCOME MEASURE USINGPATIENT REPORTED QUALITY-OF-LIFE, Neurology, 50(4), 1998, pp. 5115-5115
A REPLICATED PROSPECTIVE INVESTIGATION OF LIFE STRESS, COPING, AND DEPRESSIVE SYMPTOMS IN MULTIPLE-SCLEROSIS
Authors: AIKENS JE FISCHER JS NAMEY M RUDICK RA
Citation: Je. Aikens et al., A REPLICATED PROSPECTIVE INVESTIGATION OF LIFE STRESS, COPING, AND DEPRESSIVE SYMPTOMS IN MULTIPLE-SCLEROSIS, Journal of behavioral medicine, 20(5), 1997, pp. 433-445
IMPACT OF INTERFERON BETA-1A ON NEUROLOGIC DISABILITY IN RELAPSING MULTIPLE-SCLEROSIS
Authors: RUDICK RA GOODKIN DE JACOBS LD COOKFAIR DL HERNDON RM RICHERT JR SALAZAR AM FISCHER JS GRANGER CV SIMON JH ALAM JJ SIMONIAN NA CAMPION MK BARTOSZAK DM BOURDETTE DN BRAIMAN J BROWNSCHEIDLE CM COATS ME COHAN SL DOUGHERTY DS KINKEL RP MASS MK MUNSCHAUER FE PRIORE RL PULLICINO PM SCHEROKMAN BJ WEISTOCKGUTTMAN B WHITHAM RH
Citation: Ra. Rudick et al., IMPACT OF INTERFERON BETA-1A ON NEUROLOGIC DISABILITY IN RELAPSING MULTIPLE-SCLEROSIS, Neurology, 49(2), 1997, pp. 358-363
INTRAMUSCULAR INTERFERON BETA-1-ALPHA FOR DISEASE PROGRESSION IN RELAPSING MULTIPLE-SCLEROSIS
Authors: JACOBS LD COOKFAIR DL RUDICK RA HERNDON RM RICHERT JR SALAZAR AM FISCHER JS GOODKIN DE GRANGER CV SIMON JH ALAM JJ BARTOSZAK DM BOURDETTE DN BRAIMAN J BROWNSCHEIDLE CM COATS ME COHAN SL DOUGHERTY DS KINKEL RP MASS MK MUNSCHAUER FE PRIORE RL PULLICINO PM SCHEROKMAN BJ WEINSTOCKGUTTMAN B WHITMAN RH BAIRD WC FILLMORE M BONA LM COLONRUIZ ME NADINE BS DONOVAN A BENNETT S KIEFFER YM UMHAUER MA MILLER CE KILIC AK SARGENT EL SCHACHTER M SHUCARD DW WEIDER V CATALANO BA CERVI JM CZEKAY C FARRELL JL FILIPPINI JS MATYAS RC MICHIENZI KE ITO M OMALLEY JA ZIELEZNY MA BRUN JM DAVIDSON AL GREEN LA OREILLY KM SHELTON JA WENDE KE BARILLA DY BOYLE SL PERKINS KK PERRYMAN JE STIEBELING BG KONECSNI JF ROSS JS CHOI KS GUSTAFSON CJ QUANDT BJ SCHERZINGER AL GRIFFITH DA HARRIS JM LEZAK MD MIMICA I SAUNDERS JA COIT WE FORCE CR GILMORE FJ HARRIS LB JONES MM KAUFFMAN JA MARBERGER KE MCBRIDE JW MILLER LL WRIGHT GK BROOKS JA BROWN HR GRAVES ME SCHMIDT JA MOTHENA JW GRAFMAN JH KENWORTHY MK MORTON MM BROWN DM BROWN DC LEVY LM BORDEN EC RANSOHOFF RM VILCEK JT MCCARTHYKIRBY K CAMPION M
Citation: Ld. Jacobs et al., INTRAMUSCULAR INTERFERON BETA-1-ALPHA FOR DISEASE PROGRESSION IN RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 39(3), 1996, pp. 285-294
INTRAMUSCULAR INTERFERON-BETA-1A IN RELAPSING MULTIPLE-SCLEROSIS - ANALYSES OF QUANTITATIVE UPPER EXTREMITY TESTING
Authors: GOODKIN DE HERNDON RM JACOBS LD COOKFAIR DL RUDICK RA RICHERT JR SALAZAR AM FISCHER JS GRANGER CV SIMON JH PRIORE R
Citation: De. Goodkin et al., INTRAMUSCULAR INTERFERON-BETA-1A IN RELAPSING MULTIPLE-SCLEROSIS - ANALYSES OF QUANTITATIVE UPPER EXTREMITY TESTING, Neurology, 46(2), 1996, pp. 1074-1074
LOW-DOSE (7.5 MG) ORAL METHOTREXATE IMPROVES NEUROPSYCHOLOGICAL FUNCTION IN PATIENTS WITH CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS
Authors: FISCHER JS GOODKIN DE RUDICK RA PERKINS KK BARILLA DY DAUGHTRY MM SCHWETZ KM MEDENDORP SV
Citation: Js. Fischer et al., LOW-DOSE (7.5 MG) ORAL METHOTREXATE IMPROVES NEUROPSYCHOLOGICAL FUNCTION IN PATIENTS WITH CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS, Annals of neurology, 36(2), 1994, pp. 289-289
PLASMAPHERESIS-MEDIATED CLEARANCE OF VANCOMYCIN, GENTAMICIN, AND DIGOXIN
Authors: FRIEDBERG RC FISCHER JS MCCLELLAN SD
Citation: Rc. Friedberg et al., PLASMAPHERESIS-MEDIATED CLEARANCE OF VANCOMYCIN, GENTAMICIN, AND DIGOXIN, Transfusion, 34(10), 1994, pp. 190000003-190000003
ADVERSE-EFFECTS OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I IN OBESE INSULIN-RESISTANT TYPE-II DIABETIC-PATIENTS
Authors: JABRI N SCHALCH DS SCHWARTZ SL FISCHER JS KIPNES MS RADNIK BJ TURMAN NJ MARCSISIN VS GULER HP
Citation: N. Jabri et al., ADVERSE-EFFECTS OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I IN OBESE INSULIN-RESISTANT TYPE-II DIABETIC-PATIENTS, Diabetes, 43(3), 1994, pp. 369-374
Risultati: 1-11 |